Olendalizumab (ALXN1007) is a mouse-derived and humanized IgG2-G4-kappa antibody, targeting to Complement protein C5a (Ki=60 pM). Olendalizumab targets the complement inflammatory pathway. Moreover, Olendalizumab can be used for research of complement mediated disorder caused by corona virus[1][2].
Molekulargewicht:
(146 kDa)
Reinheit:
98.32
CAS Nummer:
[2210314-30-8]
Target-Kategorie:
Complement System
Anwendungsbeschreibung:
MCE Product type: Inhibitory Antibodies
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten